Modus Therapeutics

Stockholm, Sweden

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

$3.0M raised

Jun 2025

Post-IPO Equity

Biotechnology Clinical Trials Pharmaceutical Therapeutics

Top Investors

HealthCap Karolinska Rosetta Capital Praktikerinvest Ostersjöstiftelsen

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Modus Therapeutics

How much funding has Modus Therapeutics raised?

Modus Therapeutics has raised $3.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.

Who are Modus Therapeutics's investors?

Modus Therapeutics's investors include HealthCap, Karolinska, Rosetta Capital, Praktikerinvest, Ostersjöstiftelsen.

Where is Modus Therapeutics headquartered?

Modus Therapeutics is headquartered in Stockholm, Sweden.

What does Modus Therapeutics do?

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

What stage is Modus Therapeutics at?

Modus Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 26, 2025.

MLA

"Modus Therapeutics — Funding & Investors." VCBacked, June 26, 2025, https://www.vcbacked.co/company/modus-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). Modus Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/modus-therapeutics

Wikipedia (cite web)

{{cite web |title=Modus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/modus-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 26, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K